Skip to main content

Peer Review reports

From: Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients

Original Submission
10 Jul 2021 Submitted Original manuscript
7 Oct 2021 Reviewed Reviewer Report - Sowmyanarayanan Thuppal
21 Oct 2021 Reviewed Reviewer Report - Alexander Gough
1 Dec 2021 Author responded Author comments - Graciela Cárdenas
Resubmission - Version 2
1 Dec 2021 Submitted Manuscript version 2
7 Dec 2021 Reviewed Reviewer Report - Alexander Gough
16 Dec 2021 Reviewed Reviewer Report - Sowmyanarayanan Thuppal
31 Dec 2021 Author responded Author comments - Graciela Cárdenas
Resubmission - Version 3
31 Dec 2021 Submitted Manuscript version 3
4 Jan 2022 Reviewed Reviewer Report - Alexander Gough
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
1 Feb 2022 Editorially accepted
14 Feb 2022 Article published 10.1186/s13063-022-06075-5

You can find further information about peer review here.

Back to article page